Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8664193

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8663968

    Simian T-cell lymphotropic virus

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8663950

    Production of a monoclonal antibody therapeutic against west nile virus in plants

    THE ARIZONA BOARD OF REGENTS · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8664183

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8664177

    Peptide compositions and methods for treating patients

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8663936

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8663683

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8663681

    Oral dosage forms comprising progesterone and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8663649

    Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease

    The Board of Regents of the University of Texas System · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8663703

    Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8663633

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. CA 2881745

    COMPOSITIONS OPHTALMIQUES CONTENANT DES ACIDES GRAS OMEGA -3

    BAUSCH & LOMB [US] · Granted Thu Mar 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8668924

    Wound dressing and method for controlling severe, life-threatening bleeding

    Providence Health System—Oregon · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8668863

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8669283

    Beta-lactones as antibacterial agents

    Ludwig-Maximilians-Universitat Munchen · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8669101

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8669285

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8669081

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8669249

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8669258

    Treatment for gastroparesis using sepiapterin

    The Board of Regents of the University of Texas System · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8668911

    Streptococcus vaccine compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8673322

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8673292

    Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8673887

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8674106

    Alkynyl derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8674118

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8672906

    Medical dressing containing antimicrobial agent and related methods therefor

    Covidien LP · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8673964

    Use of drug combinations for treating insulin resistance

    DiaMedica Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8673888

    Depsipeptide for therapy of kidney cancer

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8674115

    CRTH2 modulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8673942

    Fused ring compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8673954

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8673897

    Benzodiazepinone compounds and methods of treatment using same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8673300

    Therapeutic compositions and methods for the prevention of autoimmune diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8673858

    Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

    Soricimed Biopharma Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8673843

    NMDA receptors modulators and uses thereof

    Northwestern University · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8673375

    Herbal extract products and methods

    Prime Interaction Holdings Limited · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8673332

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8673301

    YKL-40 monoclonal antibody

    The Regents of the University of California · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8680084

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8680291

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8680263

    Carbohydrate-based drug delivery polymers and conjugates thereof

    Nektar Therapeutics · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.